Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Sigma Labs

Nasdaq:SGLB
Snowflake Description

Limited growth with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SGLB
Nasdaq
$4M
Market Cap
  1. Home
  2. US
  3. Capital Goods
Company description

Sigma Labs, Inc. develops and commercializes manufacturing and materials technologies. The last earnings update was 17 days ago. More info.


Add to Portfolio Compare Print
  • Sigma Labs has significant price volatility in the past 3 months.
SGLB Share Price and Events
7 Day Returns
-11.3%
NasdaqCM:SGLB
-3.5%
US Aerospace & Defense
8%
US Market
1 Year Returns
-86.1%
NasdaqCM:SGLB
-16.7%
US Aerospace & Defense
-8.1%
US Market
SGLB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Sigma Labs (SGLB) -11.3% -56.9% -79.7% -86.1% -92.7% -99%
US Aerospace & Defense -3.5% -17.7% -32.4% -16.7% -3.3% 18%
US Market 8% -4.5% -17.8% -8.1% 13.2% 23.7%
1 Year Return vs Industry and Market
  • SGLB underperformed the Aerospace & Defense industry which returned -16.7% over the past year.
  • SGLB underperformed the Market in United States of America which returned -8.1% over the past year.
Price Volatility
SGLB
Industry
5yr Volatility vs Market

SGLB Value

 Is Sigma Labs undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Sigma Labs. This is due to cash flow or dividend data being unavailable. The share price is $2.05.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Sigma Labs's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Sigma Labs's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:SGLB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-5.37
NasdaqCM:SGLB Share Price ** NasdaqCM (2020-04-09) in USD $2.05
United States of America Aerospace & Defense Industry PE Ratio Median Figure of 39 Publicly-Listed Aerospace & Defense Companies 13.72x
United States of America Market PE Ratio Median Figure of 2,949 Publicly-Listed Companies 13.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Sigma Labs.

NasdaqCM:SGLB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:SGLB Share Price ÷ EPS (both in USD)

= 2.05 ÷ -5.37

-0.38x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sigma Labs is loss making, we can't compare its value to the US Aerospace & Defense industry average.
  • Sigma Labs is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Sigma Labs's expected growth come at a high price?
Raw Data
NasdaqCM:SGLB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.38x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
27.7%per year
United States of America Aerospace & Defense Industry PEG Ratio Median Figure of 31 Publicly-Listed Aerospace & Defense Companies 1.57x
United States of America Market PEG Ratio Median Figure of 2,009 Publicly-Listed Companies 0.9x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Sigma Labs, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Sigma Labs's assets?
Raw Data
NasdaqCM:SGLB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $0.55
NasdaqCM:SGLB Share Price * NasdaqCM (2020-04-09) in USD $2.05
United States of America Aerospace & Defense Industry PB Ratio Median Figure of 53 Publicly-Listed Aerospace & Defense Companies 1.71x
United States of America Market PB Ratio Median Figure of 5,163 Publicly-Listed Companies 1.29x
NasdaqCM:SGLB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:SGLB Share Price ÷ Book Value per Share (both in USD)

= 2.05 ÷ 0.55

3.7x

* Primary Listing of Sigma Labs.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sigma Labs is overvalued based on assets compared to the US Aerospace & Defense industry average.
X
Value checks
We assess Sigma Labs's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Aerospace & Defense industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Aerospace & Defense industry average (and greater than 0)? (1 check)
  5. Sigma Labs has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SGLB Future Performance

 How is Sigma Labs expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
27.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Sigma Labs expected to grow at an attractive rate?
  • Unable to compare Sigma Labs's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Sigma Labs's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.
  • Sigma Labs's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:SGLB Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqCM:SGLB Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 27.7%
NasdaqCM:SGLB Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 73.5%
United States of America Aerospace & Defense Industry Earnings Growth Rate Market Cap Weighted Average 10.1%
United States of America Aerospace & Defense Industry Revenue Growth Rate Market Cap Weighted Average 3.3%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 6.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:SGLB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:SGLB Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 3 -4 1
2020-12-31 1 -5 1
2020-04-10
NasdaqCM:SGLB Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 0 -6 -6
2019-09-30 0 -6 -6
2019-06-30 0 -5 -6
2019-03-31 0 -4 -6
2018-12-31 0 -4 -6
2018-09-30 0 -3 -5
2018-06-30 0 -3 -5
2018-03-31 1 -3 -5
2017-12-31 1 -3 -4
2017-09-30 1 -3 -3
2017-06-30 1 -2 -3
2017-03-31 1 -2 -3

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Sigma Labs is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Sigma Labs's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:SGLB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Sigma Labs Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:SGLB Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 -2.40 -2.40 -2.40 1.00
2020-12-31 -3.20 -3.20 -3.20 1.00
2020-04-10
NasdaqCM:SGLB Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -5.37
2019-09-30
2019-06-30 -6.58
2019-03-31 -7.39
2018-12-31 -8.10
2018-09-30 -9.14
2018-06-30 -10.46
2018-03-31 -9.83
2017-12-31 -10.05
2017-09-30 -7.93
2017-06-30 -7.63
2017-03-31 -8.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Sigma Labs will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Sigma Labs's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Sigma Labs has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SGLB Past Performance

  How has Sigma Labs performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Sigma Labs's growth in the last year to its industry (Aerospace & Defense).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Sigma Labs does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Sigma Labs's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Sigma Labs's 1-year growth to the US Aerospace & Defense industry average as it is not currently profitable.
Earnings and Revenue History
Sigma Labs's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Sigma Labs Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:SGLB Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 0.40 -6.32 4.53 0.65
2019-09-30 0.33 -6.39 4.48 0.61
2019-06-30 0.28 -6.11 4.40 0.54
2019-03-31 0.35 -5.90 4.33 0.52
2018-12-31 0.39 -5.59 4.23 0.49
2018-09-30 0.49 -5.37 3.74 0.40
2018-06-30 0.44 -5.17 3.52 0.33
2018-03-31 0.63 -4.62 3.15 0.37
2017-12-31 0.64 -4.42 3.12 0.30
2017-09-30 0.81 -3.20 2.23 0.29
2017-06-30 0.92 -2.80 2.21 0.26
2017-03-31 0.72 -2.71 2.24 0.14
2016-12-31 0.97 -2.20 2.16 0.12
2016-09-30 1.23 -2.23 2.96 0.21
2016-06-30 1.31 -2.10 2.86 0.30
2016-03-31 1.41 -1.80 2.61 0.30
2015-12-31 1.23 -1.70 2.39 0.33
2015-09-30 0.88 -1.71 2.19 0.28
2015-06-30 0.70 -1.67 2.04 0.20
2015-03-31 0.62 -3.02 1.94 0.29
2014-12-31 0.55 -3.12 2.01 0.22
2014-09-30 0.64 -3.03 1.87 0.16
2014-06-30 0.83 -2.68 1.63 0.12
2014-03-31 1.02 -1.00 1.47 0.01
2013-12-31 1.07 -0.73 1.22 0.01
2013-09-30 1.09 -0.54 1.12
2013-06-30 1.27 -0.37 1.02

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Sigma Labs has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Sigma Labs has efficiently used its assets last year compared to the US Aerospace & Defense industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Sigma Labs improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Sigma Labs's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Aerospace & Defense industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Sigma Labs has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SGLB Health

 How is Sigma Labs's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Sigma Labs's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Sigma Labs's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Sigma Labs has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Sigma Labs's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 18.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Sigma Labs Company Filings, last reported 3 months ago.

NasdaqCM:SGLB Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 0.65 0.05 0.09
2019-09-30 2.10 0.05 1.11
2019-06-30 1.40 0.05 0.70
2019-03-31 2.49 0.05 1.91
2018-12-31 1.74 0.05 1.28
2018-09-30 2.94 0.05 2.23
2018-06-30 4.13 0.05 3.52
2018-03-31 2.02 0.10 1.35
2017-12-31 3.01 0.10 1.52
2017-09-30 3.24 0.99 2.69
2017-06-30 4.22 0.97 3.38
2017-03-31 5.10 0.94 4.63
2016-12-31 0.98 0.56 0.40
2016-09-30 1.18 0.00 0.14
2016-06-30 1.74 0.00 0.55
2016-03-31 2.28 0.00 1.09
2015-12-31 3.08 0.00 1.54
2015-09-30 2.93 0.00 1.84
2015-06-30 3.27 0.00 2.22
2015-03-31 3.56 0.00 2.49
2014-12-31 3.81 0.00 2.96
2014-09-30 4.10 0.00 3.68
2014-06-30 4.43 0.00 4.32
2014-03-31 4.14 0.00 4.01
2013-12-31 1.28 0.00 0.99
2013-09-30 1.47 0.00 1.22
2013-06-30 0.36 0.00 0.46
  • Sigma Labs's level of debt (7.7%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Sigma Labs's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Sigma Labs has less than a year of cash runway based on current free cash flow.
  • Sigma Labs has less than a year of cash runway if free cash flow continues to grow at historical rates of 30% each year.
X
Financial health checks
We assess Sigma Labs's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Sigma Labs has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SGLB Dividends

 What is Sigma Labs's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Sigma Labs dividends.
If you bought $2,000 of Sigma Labs shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Sigma Labs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Sigma Labs's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:SGLB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United States of America Aerospace & Defense Industry Average Dividend Yield Market Cap Weighted Average of 19 Stocks 2.7%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1933 Stocks 2.8%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.9%
United States of America Top 25% Dividend Yield 75th Percentile 5.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqCM:SGLB Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2020-04-10

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Sigma Labs has not reported any payouts.
  • Unable to verify if Sigma Labs's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Sigma Labs's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Sigma Labs has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Sigma Labs's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Sigma Labs afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Sigma Labs has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SGLB Management

 What is the CEO of Sigma Labs's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
John Rice
COMPENSATION $365,347
AGE 73
TENURE AS CEO 2.8 years
CEO Bio

Mr. John Reynolds Rice serves as the Chief Executive Officer of Sigma Labs, Inc. He had been its Chairman since April 19, 2017 until 2019. Mr. Rice has been a President of Sigma Labs, Inc. since October 10, 2018 and served as its Interim Chief Executive Officer since July 24, 2017. Mr. Rice serves as Chief Executive Officer and President of ASiQ, LLC. He has extensive experience in business operations. He Founded ASiQ, LLC in 1990. He also served as Chief Executive Officer of Coca-Cola Bottling Company of Santa Fe, a client of ASiQ's, from 2009 to 2015. From 2010 to 2012, Mr. Rice served as Director and Contracts Officer of Detector Networks International. He frequently lectures on breakout growth strategies, crisis management, corporate turnarounds, venture capital and financial structuring and strategies. He serves as the Chairman of New Mexico Angels, Inc. Since 2005, Mr. Rice has been Director of New Mexico Angels, Inc. Since 2016, he has been Director of Akal Security, Inc. He has been an Director at Sigma Labs, Inc. since February 15, 2017. He served as Director of Detector Networks International from 2010 to 2012. Mr. Rice is an honors graduate of Harvard College.

CEO Compensation
  • John's compensation has been consistent with company performance over the past year, both up more than 20%.
  • John's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Sigma Labs management team in years:

1.5
Average Tenure
59
Average Age
  • The average tenure for the Sigma Labs management team is less than 2 years, this suggests a new team.
Management Team

John Rice

TITLE
President
COMPENSATION
$365K
AGE
73
TENURE
2.8 yrs

Darren Beckett

TITLE
Chief Technology Officer
COMPENSATION
$216K
AGE
45
TENURE
1.5 yrs

Ronald Fisher

TITLE
Vice President of Business Development
COMPENSATION
$204K
AGE
49
TENURE
4.7 yrs

Mark Ruport

TITLE
Executive Chairman
AGE
66
TENURE
0.3 yrs

Frank Orzechowski

TITLE
CFO, Treasurer & Corporate Secretary
AGE
59
TENURE
0.8 yrs
Board of Directors Tenure

Average tenure and age of the Sigma Labs board of directors in years:

2.5
Average Tenure
73.5
Average Age
  • The average tenure for the Sigma Labs board of directors is less than 3 years, this suggests a new board.
Board of Directors

Mark Ruport

TITLE
Executive Chairman
AGE
66
TENURE
0.3 yrs

Dennis Duitch

TITLE
Independent Director
COMPENSATION
$107K
AGE
74
TENURE
2.7 yrs

John Rice

TITLE
President
COMPENSATION
$365K
AGE
73
TENURE
3 yrs

Salvatore Battinelli

TITLE
Independent Director
COMPENSATION
$102K
AGE
76
TENURE
2.7 yrs

Chuck Farrar

TITLE
Member of Technical Advisory Board

Vivek Dave

TITLE
Member of Scientific & Technology Advisory Board
COMPENSATION
$46K
AGE
49
TENURE
1.3 yrs

Damon Giovanielli

TITLE
Member of Technical Advisory Board
AGE
75

Allen Mason

TITLE
Member of Technical Advisory Board
AGE
86

Jim Williams

TITLE
Member of Technical Advisory Board

Kent Summers

TITLE
Independent Director
COMPENSATION
$147K
AGE
61
TENURE
2.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
22. Aug 19 Buy Carl Schwartz Individual 08. Aug 19 09. Aug 19 50,000 $7.50 $348,746
24. May 19 Buy Carl Schwartz Individual 07. May 19 07. May 19 40,000 $14.00 $560,000
X
Management checks
We assess Sigma Labs's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Sigma Labs has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SGLB News

Simply Wall St News

Carl Schwartz Just Bought Shares In Sigma Labs, Inc. (NASDAQ:SGLB)

Check out our latest analysis for Sigma Labs Sigma Labs Insider Transactions Over The Last Year Notably, that recent purchase by insider Carl Schwartz was not the only time they bought Sigma Labs shares this year. … NasdaqCM:SGLB Recent Insider Trading, August 17th 2019 Does Sigma Labs Boast High Insider Ownership? … Insiders likely see value in Sigma Labs shares, given these transactions (along with notable insider ownership of the company).

Simply Wall St -

Introducing Sigma Labs (NASDAQ:SGLB), The Stock That Collapsed 97%

Shareholders have had an even rougher run lately, with the share price down 51% in the last 90 days. … View our latest analysis for Sigma Labs We don't think Sigma Labs's revenue of US$349,609 is enough to establish significant demand. … Sigma Labs is not the only stock that insiders are buying.

Simply Wall St -

Did Sigma Labs, Inc. (NASDAQ:SGLB) Insiders Buy Up More Shares?

So shareholders might well want to know whether insiders have been buying or selling shares in Sigma Labs, Inc. … As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.'. … Even though the purchase was made at a significantly lower price than the recent price (US$1.49), we still think insider buying is a positive

Simply Wall St -

Could Sigma Labs, Inc.'s (NASDAQ:SGLB) Investor Composition Influence The Stock Price?

The big shareholder groups in Sigma Labs, Inc. … With a market capitalization of US$19m, Sigma Labs is a small cap stock, so it might not be well known by many institutional investors. … Taking a look at the our data on the ownership groups (below), it's seems that.

Simply Wall St -

Have Insiders Been Buying Sigma Labs, Inc. (NASDAQ:SGLB) Shares?

So shareholders might well want to know whether insiders have been buying or selling shares in Sigma Labs, Inc. … Sigma Labs Insider Transactions Over The Last Year. … Over the last year, we can see that the biggest insider purchase was by Carl Schwartz for US$500k worth of shares, at about US$1.03 per share

Simply Wall St -

Could Sigma Labs Inc's (NASDAQ:SGLB) Investor Composition Impacts Your Returns?

If you want to know who really controls Sigma Labs Inc (NASDAQ:SGLB), then you'll have to look at the makeup of its share registry. … Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … Sigma Labs is not a large company by global standards.

Simply Wall St -

Sigma Labs Inc (NASDAQ:SGLB): Does The -76.24% Earnings Drop Reflect A Longer Term Trend?

After reading Sigma Labs Inc's (NASDAQ:SGLB) most recent earnings announcement (31 March 2018), I found it useful to look back at how the company has performed in the past and compare this against the latest numbers. … As a long-term investor I tend to focus on earnings trend, rather than a single number at one point in time. … SGLB is loss-making, with the most recent trailing twelve-month earnings of -US$4.77m (from 31 March 2018), which compared to last year has become

Simply Wall St -

Interested In Sigma Labs Inc (NASDAQ:SGLB)? Here's How It Performed Recently

Investors with a long-term horizong may find it valuable to assess Sigma Labs Inc's (NASDAQ:SGLB) earnings trend over time and against its industry benchmark as opposed to simply looking at a sincle earnings announcement at one point in time. … NasdaqCM:SGLB Income Statement May 31st 18 We can further assess Sigma Labs's loss by looking at what the industry has been experiencing over the past few years. … Each year, for the past five years Sigma Labs's revenue growth has been fairly soft, with an annual growth rate of -0.04%, on average.

Simply Wall St -

Does Sigma Labs Inc (NASDAQ:SGLB) Need To Issue More Shares?

How fast Sigma Labs runs down its cash supply over time is known as the cash burn rate. … NasdaqCM:SGLB Income Statement May 17th 18 When will Sigma Labs need to raise more cash? … This means that, if Sigma Labs continues to grow its opex at this rate, given how much money it currently has in the bank, it will actually need to raise capital again in within the next 6 months!

Simply Wall St -

What Investors Should Know About Sigma Labs Inc's (NASDAQ:SGLB) Financial Strength

How does SGLB’s operating cash flow stack up against its debt? … With this increase in debt, SGLB's cash and short-term investments stands at US$398.39K for investing into the business. … Investors' risk associated with debt is very low with SGLB, and the company has plenty of headroom and ability to raise debt should it need to in the future.Next Steps: SGLB’s cash flow coverage indicates it could improve its operating efficiency in order to meet demand for debt repayments should unforeseen events arise.

Simply Wall St -

SGLB Company Info

Description

Sigma Labs, Inc. develops and commercializes manufacturing and materials technologies. It offers PrintRite3D, an In-Process-Quality-Assurance (IQPA) suite of software applications primarily for 3D metal printing and additive manufacturing industries. The company’s products are used in advanced manufacturing technologies to assure part quality in real time and enhance process control practices for various industries. It also provides materials and process engineering consulting services with its PrintRite3D quality assurance software applications for advanced manufacturing. In addition, the company offers contract manufacturing services for metal additive manufacturing. It serves aerospace and defense manufacturing, energy and power generation, bio-medical manufacturing, and auto industries, as well as oil and gas exploration, extraction, and distribution areas. Sigma Labs, Inc. was founded in 2010 and is headquartered in Santa Fe, New Mexico.

Details
Name: Sigma Labs, Inc.
SGLB
Exchange: NasdaqCM
Founded: 2010
$4,087,208
1,993,760
Website: http://www.sigmalabsinc.com
Address: Sigma Labs, Inc.
3900 Paseo del Sol,
Santa Fe,
New Mexico, 87507,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM SGLB Common Stock Nasdaq Capital Market US USD 14. Sep 2010
Number of employees
Current staff
Staff numbers
21
Sigma Labs employees.
Industry
Aerospace and Defense
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/10 00:09
End of day share price update: 2020/04/09 00:00
Last estimates confirmation: 2020/03/24
Last earnings filing: 2020/03/24
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.